WhatsApp
Facebook
Instagram
X (Twitter)
YouTube
LinkedIn

24/7 Customer Support

xofluza baloxavir marboxil tablets influenza a and b 20mg

Description

 Indication & Scope

Xofluza® Baloxavir Marboxil Tablets treats acute uncomplicated influenza A and B in patients aged 12 years and older with symptom onset within 48 hours; post-exposure prophylaxis of influenza for high-risk populations after close contact with confirmed influenza cases.

  • Mechanism: Inhibits cap-dependent endonuclease of influenza virus polymerase complex, blocks viral mRNA transcription at the early stage of replication to stop virus proliferation.
  • Drug class: Cap-dependent endonuclease inhibitor; anti-influenza small-molecule antiviral agent.
  • Clinical use: Rapid one-dose antiviral therapy for acute influenza to shorten symptom duration and reduce complication risks; preventive use for exposed high-risk groups to lower infection probability.
Specification
Generic Name Baloxavir Marboxil Tablets
Brand Name Xofluza
Ingredient Baloxavir Marboxil
Dosage Form Tablets
Package 20mg*2 tablets/box;

40mg*1 tablet/box;

40mg*2 tablets/box

Conditions Treated Acute influenza A/B infection in adolescents and adults; influenza exposure prophylaxis for vulnerable crowds
Taboos Severe hypersensitivity to baloxavir marboxil or tablet excipients
Place of origin (1)2-5-1, Mishima, Settsu, Osaka 566-0022, Japan;(2)3300 Marshall Avenue, Norman, Oklahoma (OK) 73072, USA
Prescription type Prescription-only
Storage Conditions Sealed blister packs stored at 15°C–30°C, dry and away from direct sunlight
Manufacturer (1)Shionogi Pharma Co., Ltd.;

(2)Avara Pharmaceutical Technologies, Inc.

Registration Authority National Medical Products Administration (NMPA), China
Approval number HJ20210027; HJ20210028
Approval Date Jan 4, 2026
Shelf Life 24 months

How to use ?

Recommended Dose: Weight ≥40kg: single 40mg oral dose; weight <40kg: single 20mg oral dose.

 

Time: Taken once within 48 hours of the first appearance of influenza symptoms, independent of meals.

 

Instructions for use: Swallow whole tablets with water, do not crush or chew; complete the single dose without supplementary medication even if symptoms ease quickly.

 

Interaction: Polyvalent cations including iron, calcium and magnesium reduce absorption when taken simultaneously; separate administration by at least 4 hours.

 

Side effects:

1. Common: mild diarrhea, nausea, headache, sore throat.

2. Rare severe: severe allergic reactions, transient elevated liver enzymes.

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support

Certificate of Analysis

GMP Certificate

Commercial Invoice

Packing List & CPP

Cold Chain Logistics

Customs Documentation

Scientific and regulatory sources

1.WHO References
2.NMPA
3.FDA
4.EMA

FAQ

What two main therapeutic purposes are covered in the approved indications for Baloxavir Marboxil Tablets?

The medicine treats acute influenza infection and provides post-exposure preventive protection against influenza for high-risk groups.

What time limit must be followed for administration to guarantee optimal antiviral efficacy of Baloxavir Marboxil Tablets this single-dose influenza drug?

Administration must be finished within 48 hours after the first emergence of influenza symptoms.

What is the core difference in antiviral mechanism between Baloxavir Marboxil Tablets and neuraminidase inhibitor anti-influenza preparations?

It blocks early viral mRNA transcription, while neuraminidase inhibitors only prevent mature virus release from infected cells.

What population weight standard determines the two different single-dose specifications for Baloxavir Marboxil Tablets?

A weight threshold of 40 kilograms separates the 20mg and 40mg single dosage regimens.

Xofluza® | Baloxavir Marboxil Tablets | Influenza A and B | DengYueRX

INN: Baloxavir Marboxil Tablets
Indications: Influenza A and B
Dosage Form: Tablets
Strength: 20mg/tablet

Original price was: $47.65.Current price is: $40.50.

Low MOQ

WHO-GMP

Worldwide Delivery

Compliance and Regulatory Documents

Related Products

Scroll to Top

Your Cart

Your Cart

Your Cart is Empty

Start Shopping
Continue Shopping
Payment Details
Sub Total $0.00